fig1
Figure 1. Reduction in HCC incidence and all-cause mortality in patients with advanced hepatitis C who achieve an SVR to DAA. Data from the Veteran Health Administration cohort[133]. HCC: Hepatocellular carcinoma; SVR: sustained virologic response; DAA: direct-acting antiviral
